Concepedia

Elaine Cadogan

EC

37

Publications

2.7K

Citations

26

H-Index

1999

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

Loughborough University

AstraZeneca (United States)

AstraZeneca (Sweden)

AstraZeneca (Singapore)

Elaine Cadogan is an author at AstraZeneca (United Kingdom) specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

1999–2024

37

Publications

37

RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer

Cristina Cruz, Marta Castroviejo‐Bermejo, Sara Gutiérrez‐Enríquez et al. · Annals of Oncology · 2018 · 410 citations · Full text

AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity

Jacqueline H. L. Fok, Antonio Ramos‐Montoya, Mercedes Vázquez–Chantada et al. · Nature Communications · 2019 · 327 citations · Full text

Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo

Susan Ashton, Young Ho Song, Elaine Cadogan et al. · Science Translational Medicine · 2016 · 213 citations

The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung Cancer

Alice Lallo, Kristopher K. Frese, Christopher J. Morrow et al. · Clinical Cancer Research · 2018 · 155 citations · Full text

Pharmacology of the ATM Inhibitor AZD0156: Potentiation of Irradiation and Olaparib Responses Preclinically

Lucy C. Riches, Antonio G. Trinidad, Gareth Hughes et al. · Molecular Cancer Therapeutics · 2019 · 155 citations · Full text

Rows per page

1–5 of 37